CDTX vs REGN: Which Stock is Better?

Side-by-side comparison of Cidara Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

CDTX

Cidara Therapeutics Inc

REGN

Regeneron Pharmaceuticals Inc

$635.45

Key Metrics Comparison

MetricCDTXREGNWinner
Market Cap$6.96B$59.10BREGN
P/E RatioN/A13.91REGN
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze CDTX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CDTX or REGN a better investment?

Comparing CDTX and REGN: Cidara Therapeutics Inc has a market cap of $6.96B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CDTX and REGN?

CDTX (Cidara Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CDTX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CDTX or REGN?

Both CDTX and REGN show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: CDTX or REGN?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: CDTX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $6.96B for CDTX.

Should I buy CDTX or REGN in 2026?

Both CDTX and REGN have investment merit. CDTX trades at $N/A while REGN trades at $635.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CDTX and REGN stock?

Key differences: Market Cap ($6.96B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy CDTX or REGN in 2026?

The choice between CDTX and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between CDTX and REGN?

CDTX (Cidara Therapeutics Inc) has a market cap of $6.96B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.

Popular Stock Comparisons